Back

Clinical impact of transcatheter aortic valve implantation (TAVI) in frail patients: a single-center prospective study

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Diversity and specific populations in valvular heart disease Intervention ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Daniel Martinez Lopez

General University Hospital of Alicante, Alicante (Spain)

8 More presentations in this session

Presentation thumbnail
Socioeconomic disparity in utilization of transcatheter aortic valve replacement
Associate Professor Y. Lee (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Demographics and clinical outcomes of flow-gradient patterns of aortic stenosis: an analysis of the CURRENT AS Registry-2.
Doctor T. Taniguchi (Kobe, JP)
Abstract Slides Video
Presentation thumbnail
Inter-ethnic heterogeneity in valvular morphology and aortopathy of a worldwide bicuspid aortic valve cohort referred for TAVR
Doctor M. Barki (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Symptoms of Anxiety and Depression (SAD) in patients undergoing transcatheter aortic valve implantation. A multicentre Australian experience: The SAD-TAVI Study
Doctor A. Butala (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Comic-based consenting on patient-reported experience and outcome measures for transfemoral aortic valve implantation
Doctor T. Thevathasan (Berlin, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Diversity and specific populations in valvular heart disease

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Assessing TAVI: vital clinical impact or therapeutic ineffectiveness?
thumbnail
Congress Presentation
Change in frailty in patients with aortic stenosis undergoing transcatheter or surgical aortic valve replacement, a systematic review and meta-analysis
thumbnail
Congress Presentation
Pre-operative frailty and changes in health-related quality of life after transcatheter aortic valve implantation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources